Literature DB >> 15902475

Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis.

Axel Schneider1, Ulrich Sack, Karin Rothe, Joachim Bennek.   

Abstract

Despite aggressive surgical treatment, rational antibiotic therapy, and modern intensive care, generalised peritonitis remains a major threat in the paediatric age group. Several adjuvant strategies such as peritoneal saline lavage and peritoneal drainage have been utilised. Taurolidine, derived from the amino acid taurine, has bactericidic, antiendotoxic, and antiinflammatory properties. It has been introduced previously for intraoperative peritoneal lavage in treating peritonitis in adults. The aim of our study was to evaluate the effect of peritoneal taurolidine lavage on the clinical course and serological inflammation markers in children with perforated appendicitis and localised peritonitis. A series of 27 children presenting with appendicitis between January 1999 and July 2001 were included in the study after parental informed consent. All patients underwent open appendectomy. Taurolidine peritoneal lavage was applied in 15 randomly selected children (eight girls and seven boys; mean age 10 years and 10 months). Twelve children received saline peritoneal lavage and served as the control group (six girls and six boys; mean age 9 years and 7 months). Blood was taken preoperatively and on postoperative days 1, 3, 7, and 14. Full blood cell count, C-reactive protein, endotoxin, interleukin-1, interleukin-6, soluble interleukin-2 receptor, tumour necrosis factor alpha, and procalcitonin were investigated to evaluate the serological course of inflammation. Both groups initially presented with severe inflammation as evidenced clinically and serologically. The clinical postoperative course was uneventful in 13/15 patients in the treatment group and 10/12 patients in the control group. The remaining patients presented complications: intraperitoneal abscess or early postoperative bowel obstruction. With regard to the serological inflammatory parameters, no significant differences were found between the two groups except for the soluble interleukin-2-receptor on the 7th postoperative day. In conclusion, the expected reduction of endotoxin levels and inflammatory activity in the treatment group was not evident. A significant advantage of adjuvant peritoneal taurolidine lavage in the surgical therapy of children with localised peritonitis due to appendicitis could not be shown in our study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902475     DOI: 10.1007/s00383-005-1428-3

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  12 in total

Review 1.  [Peritoneal lavage in standardized peritonitis models].

Authors:  A Woltmann; M Schult; T Schiedeck; U Markert; H P Bruch
Journal:  Zentralbl Chir       Date:  1999       Impact factor: 0.942

2.  Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality.

Authors:  C Rosman; G J Westerveld; K Kooi; R P Bleichrodt
Journal:  Eur J Surg       Date:  1999-11

3.  Antioxidant status in experimental peritonitis: effects of alpha tocopherol and taurolin.

Authors:  D Konukoglu; H Iynem; E Ziylan
Journal:  Pharmacol Res       Date:  1999-03       Impact factor: 7.658

Review 4.  Novel therapies for sepsis: antiendotoxin therapies.

Authors:  Sanjay Manocha; Daniel Feinstein; Aseem Kumar; Anand Kumar
Journal:  Expert Opin Investig Drugs       Date:  2002-12       Impact factor: 6.206

Review 5.  [Therapy of peritonitis today. Surgical management and adjuvant therapy strategies].

Authors:  H B Reith
Journal:  Langenbecks Arch Chir       Date:  1997

Review 6.  [Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation].

Authors:  K H Staubach
Journal:  Langenbecks Arch Chir       Date:  1997

Review 7.  Taurine: new implications for an old amino acid.

Authors:  Georgia B Schuller-Levis; Eunkyue Park
Journal:  FEMS Microbiol Lett       Date:  2003-09-26       Impact factor: 2.742

8.  Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells.

Authors:  I Bedrosian; R D Sofia; S M Wolff; C A Dinarello
Journal:  Cytokine       Date:  1991-11       Impact factor: 3.861

9.  Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection.

Authors:  A Bauhofer; B Stinner; F Kohlert; B Reckzeh; W Lorenz; I Celik
Journal:  Br J Surg       Date:  2002-11       Impact factor: 6.939

10.  Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial.

Authors:  S M Willatts; S Radford; M Leitermann
Journal:  Crit Care Med       Date:  1995-06       Impact factor: 7.598

View more
  5 in total

Review 1.  Taurine and inflammatory diseases.

Authors:  Janusz Marcinkiewicz; Ewa Kontny
Journal:  Amino Acids       Date:  2012-07-19       Impact factor: 3.520

Review 2.  Antibiotics versus appendectomy in the management of acute appendicitis: a review of the current evidence.

Authors:  Gerard J Fitzmaurice; Billy McWilliams; Hisham Hurreiz; Emanuel Epanomeritakis
Journal:  Can J Surg       Date:  2011-10       Impact factor: 2.089

3.  Local peritoneal irrigation with intestinal alkaline phosphatase is protective against peritonitis in mice.

Authors:  Farzad Ebrahimi; Madhu S Malo; Sayeda Nasrin Alam; Angela K Moss; Halim Yammine; Sundaram Ramasamy; Brishti Biswas; Kathryn T Chen; Nur Muhammad; Golam Mostafa; H Shaw Warren; Elizabeth L Hohmann; Richard A Hodin
Journal:  J Gastrointest Surg       Date:  2011-03-01       Impact factor: 3.452

4.  Exploring the potential of taurolidine in inducing mobilization and detachment of colon cancer cells: a preliminary in-vitro study.

Authors:  Agata Mikolajczyk; Veria Khosrawipour; Hien Lau; Shiri Li; Pawel Migdal; Maya Karine Labbé; Wojciech Kielan; Jakub Nicpon; Sven Stieglitz; Tanja Khosrawipour
Journal:  BMC Pharmacol Toxicol       Date:  2022-06-13       Impact factor: 2.605

Review 5.  Outcome reporting in randomised controlled trials and meta-analyses of appendicitis treatments in children: a systematic review.

Authors:  Nigel J Hall; Mufiza Z Kapadia; Simon Eaton; Winnie W Y Chan; Cheri Nickel; Agostino Pierro; Martin Offringa
Journal:  Trials       Date:  2015-06-17       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.